Randomized, controlled trial of a 13-valent pneumococcal conjugate vaccine administered concomitantly with an influenza vaccine in healthy adults.

@article{Frenck2012RandomizedCT,
  title={Randomized, controlled trial of a 13-valent pneumococcal conjugate vaccine administered concomitantly with an influenza vaccine in healthy adults.},
  author={Robert W. Frenck and Alejandra C Gurtman and John Rubino and William A. Smith and Martin van Cleeff and Deepthi Jayawardene and Peter C. Giardina and Emilio A. Emini and William C. Gruber and Daniel J Scott and Beate Schmoele-Thoma},
  journal={Clinical and vaccine immunology : CVI},
  year={2012},
  volume={19 8},
  pages={1296-303}
}
A randomized, double-blind, phase 3 trial evaluated the immunogenicity, safety, and tolerability of a 13-valent pneumococcal conjugate vaccine (PCV13) coadministered with trivalent inactivated influenza vaccine (TIV) in pneumococcal vaccine-naive adults. Participants ages 50 to 59 years (n = 1,116) received TIV with PCV13 (group 1) or placebo (group 2) (1:1 randomization); 1 month later, group 1 received placebo and group 2 received PCV13. A hemagglutination inhibition (HAI) assay for TIV and a… CONTINUE READING

Connections & Topics

Mentioned Connections BETA
A randomized , double - blind , phase 3 trial evaluated the immunogenicity , safety , and tolerability of a 13-valent pneumococcal conjugate vaccine ( PCV13 ) coadministered with trivalent inactivated influenza vaccine ( TIV ) in pneumococcal vaccine - naive adults .
A randomized , double - blind , phase 3 trial evaluated the immunogenicity , safety , and tolerability of a 13-valent pneumococcal conjugate vaccine ( PCV13 ) coadministered with trivalent inactivated influenza vaccine ( TIV ) in pneumococcal vaccine - naive adults .
A randomized , double - blind , phase 3 trial evaluated the immunogenicity , safety , and tolerability of a 13-valent pneumococcal conjugate vaccine ( PCV13 ) coadministered with trivalent inactivated influenza vaccine ( TIV ) in pneumococcal vaccine - naive adults .
A randomized , double - blind , phase 3 trial evaluated the immunogenicity , safety , and tolerability of a 13-valent pneumococcal conjugate vaccine ( PCV13 ) coadministered with trivalent inactivated influenza vaccine ( TIV ) in pneumococcal vaccine - naive adults .
A randomized , double - blind , phase 3 trial evaluated the immunogenicity , safety , and tolerability of a 13-valent pneumococcal conjugate vaccine ( PCV13 ) coadministered with trivalent inactivated influenza vaccine ( TIV ) in pneumococcal vaccine - naive adults .
A randomized , double - blind , phase 3 trial evaluated the immunogenicity , safety , and tolerability of a 13-valent pneumococcal conjugate vaccine ( PCV13 ) coadministered with trivalent inactivated influenza vaccine ( TIV ) in pneumococcal vaccine - naive adults .
All Topics